Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 Life Science Investing
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis Life Science Investing
Rakovina Therapeutics Reports Strong Industry Validation and Emerging Collaborations Following 9th Annual DDR Inhibitors Summit Life Science Investing
MiNK Therapeutics Presents New Data of allo-iNKT Cell Therapy as a Potential Disease-Modifying Approach in Idiopathic Pulmonary Fibrosis at Keystone Symposia Life Science Investing
Marvel Biosciences Receives Japanese Patent Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204 Life Science Investing
Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results Life Science Investing
Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center Biotech Investing
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application for PRT12396, a Mutant-selective JAK2V617F Inhibitor Life Science Investing
Spruce Biosciences Adds Regulatory and Clinical Development Expertise to Leadership Team Life Science Investing
Spruce Biosciences Adds Regulatory and Clinical Development Expertise to Leadership Team Life Science Investing
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
